Literature DB >> 6551193

A solid-phase radioimmunoassay to detect antibodies produced by hybridomas to antigens derived from human melanoma cells.

P J Kelleher, H L Mathews, L K Woods, R S Farr, P Minden.   

Abstract

A solid-phase radioimmunoassay to detect antibodies that react with antigens derived from human melanoma cells is described. A soluble preparation derived from Nonidet P-40 lysates of tissue-cultured melanoma cells was dried on the surfaces of wells of polyvinyl chloride microtiter plates and fixed with 0.02% glutaraldehyde. Antibody preparations were added and incubated for 18 h at 4 degrees C. The wells were washed and bound antibodies were detected using radioactive Staphyloccoccal protein A (125I-SpA). Optimal conditions are described for all the steps employed. Concentrations of antigen selected, the amount of 125I-SpA employed and the duration of incubation of antibodies with antigen were found to be critical. The assay was sensitive and reproducible, and lent itself to the simultaneous evaluation of many individual antibody samples in a short period of time. The assay was particularly valuable for rapid screening of hybridoma supernatants for antibodies to antigens derived from melanoma cells and from a panel of other tumor and normal cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6551193     DOI: 10.1007/bf00205358

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  23 in total

1.  Comparison of direct and indirect solid-phase microradioimmunoassays for the detection of viral antigens and antiviral antibody.

Authors:  J D Rosenthal; K Hayashi; A L Notkins
Journal:  Appl Microbiol       Date:  1973-04

2.  Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.

Authors:  P Minden; J K McClatchy; M Wainberg; D W Weiss
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

3.  Use of an enzyme-linked immunosorbent assay (ELISA) for screening of hybridoma antibodies against cell surface antigens.

Authors:  L Suter; J Brüggen; C Sorg
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

4.  Membrane antigens detected on human lung carcinoma cells by hybridoma monoclonal antibody.

Authors:  M Kasai; R E Saxton; E C Holmes; M W Burk; D L Morton
Journal:  J Surg Res       Date:  1981-04       Impact factor: 2.192

Review 5.  Antibody production by hybridomas.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

Review 6.  Production of monoclonal antibodies: strategy and tactics.

Authors:  S F de StGroth; D Scheidegger
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

7.  Protein antigens of normal and malignant human cells identified by immunoprecipitation with monoclonal antibodies.

Authors:  J P Brown; P W Wright; C E Hart; R G Woodbury; K E Hellström; I Hellström
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

8.  Antibody responses of tumor-bearing mice to their own tumors captured and perpetuated as hybridomas.

Authors:  C R Simrell; P A Klein
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

9.  The use of cellular immunoadsorbents to prepare polyclonal antibodies that distinguish between antigens derived from human melanoma cells and autologous lymphocytes.

Authors:  P J Kelleher; H L Mathews; G E Moore; P Minden
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

10.  Human melanoma associated antigens: a solid-phase assay for detection of specific antibody.

Authors:  A C Morgan; D R Galloway; B S Wilson; R A Reisfeld
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

View more
  3 in total

1.  Mab labelled liposomes as selective vehicles for drugs in H.I.V. infected cells.

Authors:  G Rombi; G Piu; S Piro; V Anedda
Journal:  Cytotechnology       Date:  1993-01       Impact factor: 2.058

2.  Immunological evaluation of a component isolated from Mycobacterium bovis BCG with a monoclonal antibody to M. bovis BCG.

Authors:  P Minden; P J Kelleher; J H Freed; L D Nielsen; P J Brennan; L McPheron; J K McClatchy
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

3.  The use of cellular immunoadsorbents to prepare polyclonal antibodies that distinguish between antigens derived from human melanoma cells and autologous lymphocytes.

Authors:  P J Kelleher; H L Mathews; G E Moore; P Minden
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.